DSCOY
Daiichi Sankyo
Phase 3
Estimated
Ifinatamab deruxtecan
Small Cell Lung Cancer
T-minus 252 days
Apr 30, 2027
ClinicalTrials.gov
verified 2mo ago
Countdown card →